E Chung1, C T Van, I Wilson, R A Cartmill. 1. Department of Urology, Princess Alexandra Hospital, Ipswich Rd, Brisbane, QLD, 4103, Australia. ericchg@hotmail.com
Abstract
PURPOSE: To evaluate the clinical outcomes of penile prosthesis implantation for the treatment for erectile dysfunction (ED) over 3 decades in a centre of excellence. METHODS: A total of 955 penile prostheses were implanted between June 1981 and June 2010. The mean age of the men was 53.2 (28-80) years, and the mean follow-up was 76 (12-355) months. A total of 771 men had primary implants. The most common implant was Ultrex cylinder (54 %), and the main cause of ED was organic (32 %). RESULTS: Primary implants showed higher rate of intra-operative complications than revision surgery (3.5 vs. 0.1 %) (p < 0.05). Prosthesis infection occurred in 0.8 % and equal incidence between diabetic and pelvic trauma patients. The average time to prosthetic revision was 102 (30-210) months. Kaplan-Meier estimates of overall penile prosthesis survival at 5 and 10 years were around 90.8 and 85.0 %. The most common mechanical failures were fluid loss (75 %). The majority of men were satisfied with the surgical outcomes, and 90 % of men would undergo penile prosthesis implant again. CONCLUSIONS: Penile prosthesis surgery is a safe and durable treatment option for male ED. Strict adherence to antimicrobial prophylaxis and surgical practice is paramount to ensure low complication rates and high patient satisfaction rate.
PURPOSE: To evaluate the clinical outcomes of penile prosthesis implantation for the treatment for erectile dysfunction (ED) over 3 decades in a centre of excellence. METHODS: A total of 955 penile prostheses were implanted between June 1981 and June 2010. The mean age of the men was 53.2 (28-80) years, and the mean follow-up was 76 (12-355) months. A total of 771 men had primary implants. The most common implant was Ultrex cylinder (54 %), and the main cause of ED was organic (32 %). RESULTS: Primary implants showed higher rate of intra-operative complications than revision surgery (3.5 vs. 0.1 %) (p < 0.05). Prosthesis infection occurred in 0.8 % and equal incidence between diabetic and pelvic traumapatients. The average time to prosthetic revision was 102 (30-210) months. Kaplan-Meier estimates of overall penile prosthesis survival at 5 and 10 years were around 90.8 and 85.0 %. The most common mechanical failures were fluid loss (75 %). The majority of men were satisfied with the surgical outcomes, and 90 % of men would undergo penile prosthesis implant again. CONCLUSIONS: Penile prosthesis surgery is a safe and durable treatment option for male ED. Strict adherence to antimicrobial prophylaxis and surgical practice is paramount to ensure low complication rates and high patient satisfaction rate.
Authors: Mary Jo Brinkman; Gerard D Henry; Steven K Wilson; John R Delk; George A Denny; Michael Young; Mario A Cleves Journal: J Urol Date: 2005-07 Impact factor: 7.450
Authors: Gerard D Henry; Neil S Kansal; Mark Callaway; Tobin Grigsby; Jonathon Henderson; James Noble; Thomas Palmer; Mario A Cleves; John K Ludlow; Caroline J Simmons; Thomas M Mook Journal: J Urol Date: 2009-01-18 Impact factor: 7.450
Authors: Eric Chung; Carlo Bettocchi; Paulo Egydio; Chris Love; Daniar Osmonov; Sean Park; David Ralph; Zhong Cheng Xin; Gerald Brock Journal: Nat Rev Urol Date: 2022-06-16 Impact factor: 16.430
Authors: Joseph M Israeli; Soum D Lokeshwar; Iakov V Efimenko; Thomas A Masterson; Ranjith Ramasamy Journal: Int J Impot Res Date: 2021-11-06 Impact factor: 2.408